Fatty acid‐binding protein 5 limits the generation of Foxp3+ regulatory T cells through regulating plasmacytoid dendritic cell function in the tumor microenvironment. Issue 1 (20th September 2021)
- Record Type:
- Journal Article
- Title:
- Fatty acid‐binding protein 5 limits the generation of Foxp3+ regulatory T cells through regulating plasmacytoid dendritic cell function in the tumor microenvironment. Issue 1 (20th September 2021)
- Main Title:
- Fatty acid‐binding protein 5 limits the generation of Foxp3+ regulatory T cells through regulating plasmacytoid dendritic cell function in the tumor microenvironment
- Authors:
- Kobayashi, Shuhei
Wannakul, Tunyanat
Sekino, Kaname
Takahashi, Yu
Kagawa, Yoshiteru
Miyazaki, Hirofumi
Umaru, Banlanjo Abdulaziz
Yang, Shuhan
Yamamoto, Yui
Owada, Yuji - Abstract:
- Abstract: Plasmacytoid dendritic cells (pDCs) promote viral elimination by producing large amounts of Type I interferon. Recent studies have shown that pDCs regulate the pathogenesis of diverse inflammatory diseases, such as cancer. Fatty acid‐binding protein 5 (FABP5) is a cellular chaperone of long‐chain fatty acids that induce biological responses. Although the effects of FABP‐mediated lipid metabolism are well studied in various immune cells, its role in pDCs remains unclear. This study, which compares wild‐type and Fabp5 −/− mice, provides the first evidence that FABP5‐mediated lipid metabolism regulates the commitment of pDCs to inflammatory vs tolerogenic gene expression patterns in the tumor microenvironment and in response to toll‐like receptor stimulation. Additionally, we demonstrated that FABP5 deficiency in pDCs affects the surrounding cellular environment, and that FABP5 expression in pDCs supports the appropriate generation of regulatory T cells (Tregs). Collectively, our findings reveal that pDC FABP5 acts as an important regulator of tumor immunity by controlling lipid metabolism. Abstract : What's new? Regulatory T cells (Tregs) obstruct antitumour immunity, promoting tumour microenvironment formation. Although plasmacytoid DCs (pDCs) are pivotal Treg inducers, the effects of FABP5‐mediated lipid homeostasis in pDCs on Tregs remain unclear. This study suggests that FABP5‐mediated lipid metabolism regulates the commitment of pDCs to inflammatory versusAbstract: Plasmacytoid dendritic cells (pDCs) promote viral elimination by producing large amounts of Type I interferon. Recent studies have shown that pDCs regulate the pathogenesis of diverse inflammatory diseases, such as cancer. Fatty acid‐binding protein 5 (FABP5) is a cellular chaperone of long‐chain fatty acids that induce biological responses. Although the effects of FABP‐mediated lipid metabolism are well studied in various immune cells, its role in pDCs remains unclear. This study, which compares wild‐type and Fabp5 −/− mice, provides the first evidence that FABP5‐mediated lipid metabolism regulates the commitment of pDCs to inflammatory vs tolerogenic gene expression patterns in the tumor microenvironment and in response to toll‐like receptor stimulation. Additionally, we demonstrated that FABP5 deficiency in pDCs affects the surrounding cellular environment, and that FABP5 expression in pDCs supports the appropriate generation of regulatory T cells (Tregs). Collectively, our findings reveal that pDC FABP5 acts as an important regulator of tumor immunity by controlling lipid metabolism. Abstract : What's new? Regulatory T cells (Tregs) obstruct antitumour immunity, promoting tumour microenvironment formation. Although plasmacytoid DCs (pDCs) are pivotal Treg inducers, the effects of FABP5‐mediated lipid homeostasis in pDCs on Tregs remain unclear. This study suggests that FABP5‐mediated lipid metabolism regulates the commitment of pDCs to inflammatory versus tolerogenic gene expression patterns in the tumour microenvironment. Furthermore, FABP5 deficiency in mice attenuated tumour progression and decreased the tumour microenvironment Treg population. Loss of FABP5 from pDCs also impaired Treg induction. The findings suggest that pDC FABP5 acts as an important regulator of tumour immunity by controlling lipid metabolism. … (more)
- Is Part Of:
- International journal of cancer. Volume 150:Issue 1(2022)
- Journal:
- International journal of cancer
- Issue:
- Volume 150:Issue 1(2022)
- Issue Display:
- Volume 150, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 150
- Issue:
- 1
- Issue Sort Value:
- 2022-0150-0001-0000
- Page Start:
- 152
- Page End:
- 163
- Publication Date:
- 2021-09-20
- Subjects:
- FABP -- pDC -- translational research -- Treg -- tumor microenvironment
Cancer -- Periodicals
Cancer -- Prevention -- Periodicals
616.994 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ijc.33777 ↗
- Languages:
- English
- ISSNs:
- 0020-7136
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.156000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26147.xml